<%@ page language="java" contentType="text/html; charset=UTF-8" pageEncoding="UTF-8"%>
<%@ taglib prefix="c" uri="http://java.sun.com/jsp/jstl/core"%>
<%@ taglib prefix="fn" uri="http://java.sun.com/jsp/jstl/functions"%>
<div class="content">
	<div class="report-content">
		<section>
			<h4>检测结果：</h4>
			<div class="result-div">
				<p class="main">
					发现<strong>致病相关</strong>突变！
				</p>
				<p class="notice">注： 本报告中&nbsp;“致病相关”&nbsp;是指本系统采集到的已知研究结论中，受检人样本中存在的突变与疾病有相关性。</p>
			</div>
		</section>
		<section>
			<h4>结果说明：</h4>
			<table class="table table-main -report">
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045572</td>
					<td>99.6350364963504</td>
					<td>chr17_43045347_43046067</td>
					<td>226</td>
					<td>G</td>
					<td>274</td>
					<td>A:0;G:273;C:0;T:1;tot:274</td>
					<td>0</td>
					<td>273</td>
					<td>0</td>
					<td>1</td>
					<td>274</td>
					<td>0</td>
					<td>0.996350364963504</td>
					<td>0</td>
					<td>0.00364963503649635</td>
					<td>0.0241288360030557</td>
					<td>NM_007294.3(BRCA1):c.*106C>G</td>
					<td>c.*106C>G</td>
					<td>-</td>
					<td>BRCA1</td>
					<td>Breast-ovarian cancer, familial 1</td>
					<td>GMAF:0.00020(A)</td>
					<td>Benign(Last reviewed: Jan 1, 2000)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045572</td>
					<td>GRCh38</td>
					<td>125875</td>
					<td>131413</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045620</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>274</td>
					<td>G</td>
					<td>270</td>
					<td>A:0;G:270;C:0;T:0;tot:270</td>
					<td>0</td>
					<td>270</td>
					<td>0</td>
					<td>0</td>
					<td>270</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.*58C>T</td>
					<td>c.*58C>T</td>
					<td>-</td>
					<td>BRCA1</td>
					<td>Hereditary breast and ovarian cancer syndrome</td>
					<td>GMAF:0.00060(A)</td>
					<td>Uncertain significance(Last reviewed: Oct 28, 2015)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045620</td>
					<td>GRCh38</td>
					<td>220816</td>
					<td>222644</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045642</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>296</td>
					<td>G</td>
					<td>282</td>
					<td>A:0;G:282;C:0;T:0;tot:282</td>
					<td>0</td>
					<td>282</td>
					<td>0</td>
					<td>0</td>
					<td>282</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.*36C>G</td>
					<td>c.*36C>G</td>
					<td>-</td>
					<td>BRCA1</td>
					<td>Breast-ovarian cancer, familial 1</td>
					<td>GO-ESP:0.01561(C), GMAF:0.01560(C)</td>
					<td>Benign(Last reviewed: Jan 12, 2015)</td>
					<td>reviewed by expert panel</td>
					<td>17</td>
					<td>43045642</td>
					<td>GRCh38</td>
					<td>125873</td>
					<td>131411</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045658</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>312</td>
					<td>G</td>
					<td>290</td>
					<td>A:0;G:290;C:0;T:0;tot:290</td>
					<td>0</td>
					<td>290</td>
					<td>0</td>
					<td>0</td>
					<td>290</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.*20C>T</td>
					<td>c.*20C>T</td>
					<td>-</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast</td>
					<td></td>
					<td>Benign(Last reviewed: Oct 7, 2014)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045658</td>
					<td>GRCh38</td>
					<td>182099</td>
					<td>180810</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045677</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>331</td>
					<td>G</td>
					<td>318</td>
					<td>A:0;G:318;C:0;T:0;tot:318</td>
					<td>0</td>
					<td>318</td>
					<td>0</td>
					<td>0</td>
					<td>318</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.*1C>T</td>
					<td>c.*1C>T</td>
					<td>-</td>
					<td>BRCA1</td>
					<td>Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Likely benign(Last reviewed: Jan 21, 2015)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045677</td>
					<td>GRCh38</td>
					<td>141903</td>
					<td>151617</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045684</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>338</td>
					<td>G</td>
					<td>326</td>
					<td>A:0;G:326;C:0;T:0;tot:326</td>
					<td>0</td>
					<td>326</td>
					<td>0</td>
					<td>0</td>
					<td>326</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5586C>T (p.His1862=)</td>
					<td>c.5586C>T</td>
					<td>p.His1862</td>
					<td>BRCA1</td>
					<td>Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Likely benign(Last reviewed: Jun 9, 2014)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045684</td>
					<td>GRCh38</td>
					<td>185343</td>
					<td>184861</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045685</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>339</td>
					<td>T</td>
					<td>325</td>
					<td>A:0;G:0;C:0;T:325;tot:325</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>325</td>
					<td>325</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5585A>T (p.His1862Leu)</td>
					<td>c.5585A>T</td>
					<td>p.His1862Leu</td>
					<td>BRCA1</td>
					<td>Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome</td>
					<td></td>
					<td>Uncertain significance(Last reviewed: Aug 6, 2015)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045685</td>
					<td>GRCh38</td>
					<td>55637</td>
					<td>70304</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045691</td>
					<td>99.6815286624204</td>
					<td>chr17_43045347_43046067</td>
					<td>345</td>
					<td>T</td>
					<td>314</td>
					<td>A:0;G:1;C:0;T:313;tot:314</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>313</td>
					<td>314</td>
					<td>0</td>
					<td>0.00318471337579618</td>
					<td>0</td>
					<td>0.996815286624204</td>
					<td>0.0214898055290561</td>
					<td>NM_007294.3(BRCA1):c.5579A>C (p.His1860Pro)</td>
					<td>c.5579A>C</td>
					<td>p.His1860Pro</td>
					<td>BRCA1</td>
					<td>not provided</td>
					<td></td>
					<td>Benign(Last reviewed: Jul 13, 2012)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045691</td>
					<td>GRCh38</td>
					<td>41833</td>
					<td>50272</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045692</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>346</td>
					<td>G</td>
					<td>312</td>
					<td>A:0;G:311;C:0;T:0;tot:311</td>
					<td>0</td>
					<td>311</td>
					<td>0</td>
					<td>0</td>
					<td>311</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5578dupC (p.His1860Profs)</td>
					<td>c.5578dupC</td>
					<td>p.His1860Profs</td>
					<td>BRCA1</td>
					<td>Breast-ovarian cancer, familial 1</td>
					<td></td>
					<td>Likely pathogenic(Last reviewed: Jul 25, 2006)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045692</td>
					<td>GRCh38</td>
					<td>37683</td>
					<td>46239</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045694</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>348</td>
					<td>G</td>
					<td>312</td>
					<td>A:0;G:312;C:0;T:0;tot:312</td>
					<td>0</td>
					<td>312</td>
					<td>0</td>
					<td>0</td>
					<td>312</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5576C>G (p.Pro1859Arg)</td>
					<td>c.5576C>G</td>
					<td>p.Pro1859Arg</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Benign(Last reviewed: Aug 10, 2015)</td>
					<td>reviewed by expert panel</td>
					<td>17</td>
					<td>43045694</td>
					<td>GRCh38</td>
					<td>55634</td>
					<td>70301</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045697</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>351</td>
					<td>A</td>
					<td>289</td>
					<td>A:289;G:0;C:0;T:0;tot:289</td>
					<td>289</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>289</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5573T>C (p.Ile1858Thr)</td>
					<td>c.5573T>C</td>
					<td>p.Ile1858Thr</td>
					<td>BRCA1</td>
					<td>Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Conflicting interpretations of pathogenicity(Last reviewed: Nov 4, 2015)</td>
					<td>criteria provided, conflicting interpretations</td>
					<td>17</td>
					<td>43045697</td>
					<td>GRCh38</td>
					<td>186496</td>
					<td>184863</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045698</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>352</td>
					<td>T</td>
					<td>290</td>
					<td>A:0;G:0;C:0;T:290;tot:290</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>290</td>
					<td>290</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5572A>C (p.Ile1858Leu)</td>
					<td>c.5572A>C</td>
					<td>p.Ile1858Leu</td>
					<td>BRCA1</td>
					<td>Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Benign(Last reviewed: Aug 10, 2015)</td>
					<td>reviewed by expert panel</td>
					<td>17</td>
					<td>43045698</td>
					<td>GRCh38</td>
					<td>183951</td>
					<td>184864</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045699</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>353</td>
					<td>C</td>
					<td>291</td>
					<td>A:0;G:0;C:291;T:0;tot:291</td>
					<td>0</td>
					<td>0</td>
					<td>291</td>
					<td>0</td>
					<td>291</td>
					<td>0</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5571G>C (p.Gln1857His)</td>
					<td>c.5571G>C</td>
					<td>p.Gln1857His</td>
					<td>BRCA1</td>
					<td>Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Uncertain significance(Last reviewed: Jun 2, 2014)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045699</td>
					<td>GRCh38</td>
					<td>185265</td>
					<td>184865</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045704</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>358</td>
					<td>G</td>
					<td>291</td>
					<td>A:0;G:291;C:0;T:0;tot:291</td>
					<td>0</td>
					<td>291</td>
					<td>0</td>
					<td>0</td>
					<td>291</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5566C>T (p.Pro1856Ser)</td>
					<td>c.5566C>T</td>
					<td>p.Pro1856Ser</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast|Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Conflicting interpretations of pathogenicity, not provided(Last reviewed: Feb 24, 2014)</td>
					<td>criteria provided, conflicting interpretations</td>
					<td>17</td>
					<td>43045704</td>
					<td>GRCh38</td>
					<td>55632</td>
					<td>70299</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045707</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>361</td>
					<td>T</td>
					<td>233</td>
					<td>A:0;G:0;C:0;T:233;tot:233</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>233</td>
					<td>233</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5563delAins6</td>
					<td>c.5563delAins6</td>
					<td>-</td>
					<td>BRCA1</td>
					<td>Breast-ovarian cancer, familial 1</td>
					<td></td>
					<td>Pathogenic(Last reviewed: Jun 12, 2000)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045707</td>
					<td>GRCh38</td>
					<td>125871</td>
					<td>131409</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045708</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>362</td>
					<td>C</td>
					<td>233</td>
					<td>A:0;G:0;C:233;T:0;tot:233</td>
					<td>0</td>
					<td>0</td>
					<td>233</td>
					<td>0</td>
					<td>233</td>
					<td>0</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5562G>A (p.Leu1854=)</td>
					<td>c.5562G>A</td>
					<td>p.Leu1854</td>
					<td>BRCA1</td>
					<td>Hereditary cancer-predisposing syndrome</td>
					<td></td>
					<td>Likely benign(Last reviewed: Apr 5, 2014)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045708</td>
					<td>GRCh38</td>
					<td>184730</td>
					<td>184866</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045709</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>363</td>
					<td>A</td>
					<td>233</td>
					<td>A:233;G:0;C:0;T:0;tot:233</td>
					<td>233</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>233</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5561T>C (p.Leu1854Pro)</td>
					<td>c.5561T>C</td>
					<td>p.Leu1854Pro</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast|Breast-ovarian cancer, familial 1</td>
					<td></td>
					<td>Uncertain significance(Last reviewed: Feb 7, 2012)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045709</td>
					<td>GRCh38</td>
					<td>55631</td>
					<td>70298</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045711</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>365</td>
					<td>G</td>
					<td>238</td>
					<td>A:0;G:238;C:0;T:0;tot:238</td>
					<td>0</td>
					<td>238</td>
					<td>0</td>
					<td>0</td>
					<td>238</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5559C>A (p.Tyr1853Ter)</td>
					<td>c.5559C>A</td>
					<td>p.Tyr1853Ter</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast|Breast-ovarian cancer, familial 1</td>
					<td></td>
					<td>Pathogenic(Last reviewed: Nov 25, 2004)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045711</td>
					<td>GRCh38</td>
					<td>55629</td>
					<td>70296</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045712</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>366</td>
					<td>T</td>
					<td>236</td>
					<td>A:0;G:0;C:0;T:236;tot:236</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>236</td>
					<td>236</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5558A>G (p.Tyr1853Cys)</td>
					<td>c.5558A>G</td>
					<td>p.Tyr1853Cys</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast|Breast-ovarian cancer, familial 1</td>
					<td></td>
					<td>Uncertain significance(Last reviewed: Jun 20, 2002)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045712</td>
					<td>GRCh38</td>
					<td>55627</td>
					<td>70294</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045714</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>368</td>
					<td>G</td>
					<td>237</td>
					<td>A:0;G:237;C:0;T:0;tot:237</td>
					<td>0</td>
					<td>237</td>
					<td>0</td>
					<td>0</td>
					<td>237</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5556C>G (p.Thr1852=)</td>
					<td>c.5556C>G</td>
					<td>p.Thr1852</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast|Breast-ovarian cancer, familial 1</td>
					<td></td>
					<td>Uncertain significance(Last reviewed: Nov 25, 2004)</td>
					<td>no assertion criteria provided</td>
					<td>17</td>
					<td>43045714</td>
					<td>GRCh38</td>
					<td>55626</td>
					<td>70293</td>
					<td>-</td>
				</tr>
				<tr>
					<td>BRCA1</td>
					<td>chr17</td>
					<td>43045715</td>
					<td>100</td>
					<td>chr17_43045347_43046067</td>
					<td>369</td>
					<td>G</td>
					<td>237</td>
					<td>A:0;G:237;C:0;T:0;tot:237</td>
					<td>0</td>
					<td>237</td>
					<td>0</td>
					<td>0</td>
					<td>237</td>
					<td>0</td>
					<td>1</td>
					<td>0</td>
					<td>0</td>
					<td>0</td>
					<td>NM_007294.3(BRCA1):c.5555C>T (p.Thr1852Ile)</td>
					<td>c.5555C>T</td>
					<td>p.Thr1852Ile</td>
					<td>BRCA1</td>
					<td>Familial cancer of breast</td>
					<td></td>
					<td>Uncertain significance(Last reviewed: Apr 1, 2014)</td>
					<td>criteria provided, single submitter</td>
					<td>17</td>
					<td>43045715</td>
					<td>GRCh38</td>
					<td>182174</td>
					<td>180811</td>
					<td>-</td>
				</tr>
				<tr>
					<td>运行结果异常</td>
					<td>&nbsp;</td>
					<td>&nbsp;</td>
				</tr>
			</table>
			<p class="notice">1.根据......</p>
			<p class="notice">1.根据......</p>
			<p class="notice">1.根据......</p>
			<p class="notice">1.根据......</p>
		</section>
	</div>
</div>